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Background: Airways of cystic fibrosis (CF) patients are colonised with bacteria early in life. We aimed to analyse differences between results of
simultaneously taken upper airway (UAW) and lower airway (LAW) cultures, to describe clinical characteristics of patients with positive versus
negative cultures and to follow up the patients with P. aeruginosa positive UAW cultures.
Methods: Bacteriological and clinical data from 157 children were collected during annual check up. The number of positive UAW and LAW
cultures and correspondence between these results and clinical characteristics were analysed.
Results: Positive LAW and UAW cultures were found in 79.6% and 43.9% of patients respectively (pb0.001). Patients with positive LAW
cultures were significantly older (11.9 vs. 9.8 years, pb0.05) and had more LAW symptoms (73.6% vs. 46.7%, pb0.05), especially when
P. aeruginosa was found. Patients with positive UAW cultures (especially S. aureus) had more nasal discharge (50.7% vs. 25.0%, pb0.001). In
65% of patients with positive UAW and negative LAW culture for P. aeruginosa the next LAW became P. aeruginosa positive.
Conclusion: UAW cultures and LAW cultures differ in children with CF and there are differences in clinical characteristics between patients with
positive versus negative culture results. P. aeruginosa positive UAW cultures appeared to precede positive LAW cultures in a substantial part of
patients, suggesting some kind of cross-infection between the UAW and LAW.
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In cystic fibrosis (CF) patients progressive respiratory disease is
the most important cause of morbidity and mortality [1]. The most
important microorganisms causing airway infections in younger
patients are Staphylococcus aureus (SA) and Haemophilus
influenzae. Pseudomonas aeruginosa (PA) can be cultured from
the majority of patients during later life [2]. These bacteria are
present in both upper airways (UAW) and lower airways (LAW).
The relationship between cultures from the UAW and LAW
has been studied extensively in patients with COPD [3,4], but
until recently there were hardly any studies on this relationship
in CF patients.⁎ Corresponding author. Tel.: +31 88 7553201; fax: +31 88 7554747.
E-mail address: h.arets@umcutrecht.nl (H.G.M. Arets).
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doi:10.1016/j.jcf.2010.01.001Also the relation between UAW and LAW results and
clinical symptoms is not clear.
Early and aggressive inhaled antibiotic treatment is advo-
cated in case of first isolation of PA from the LAW in order to
prevent chronic infections and deterioration of lung function
[5]. Taylor et al. already suggested, some 20 years ago, that
colonisation of the UAWmay precede spread to the LAW in CF
patients [6]. Mainz et al. recently drew attention to the possible
role of the UAW as a reservoir for PA and SA in patients of all
ages with CF, especially adults [7]. This hypothesis has two
important implications. First, detection of these microorganisms
from the UAW in an early stage, i.e. before colonising the lungs,
might be important. This early tracing with e.g. bacterial
antibodies has not shown to be very sensitive [8,9] and better
methods have to be found. Secondly, most eradication protocols
for PA, using inhaled antibiotics leave the UAW untreated andd by Elsevier B.V. All rights reserved.
Table 1
Clinical characteristics of 157 included patients.
Characteristics Total (n=157)
Sex female 75 (48%)
Median age, years 11.3 [3.7–19.0]
Mean BMI, Z-score −0.3 [−2.3–2.2]
Lower airway cultures
Cough swabs 81 (52%)
Sputum cultures 76 (48%)
Lung function (n=154)
Mean FEV1% pred. 90.2 [44–132]
Pulmonary symptoms
Cough 128 (82%)
Sputum production 107 (68%)
Ear–nose–throat symptoms
Nasal blockage 22 (14%)
Rhinorrhea 21 (13%)
Headache 9 (6%)
Ear–nose–throat examination
Nasal polyposis 82 (52%)
Nasal discharge 57 (36%)
Mucosal oedema 10 (6%)
Data are given as number of patients and percentage or mean and range. N:
number of patients. BMI: body mass index. FEV1% pred: Forced expiratory
volume in one second expressed as % of predicted.
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UAW to LAW.
In the present study we specifically studied a large paediatric
age group. We wanted to analyse 1) if there are differences
between the outcome of nasal (UAW) and sputum (LAW)
cultures taken from children with CF; 2) the clinical
characteristics of CF patients with positive and negative
UAW and LAW cultures and 3) the follow up cultures of
patients with PA only cultured from the UAW.
2. Methods
In the CF Centre Utrecht 238 children with CF are treated.
During all standard 3 months clinical controls cultures from
LAW are collected. All children from the age of 4 years visit the
ear–nose–throat (ENT) surgeon during annual check up and
more often if necessary. We included children who had at least
one annual check up in 2006 to 2008 and were seen by the ENT
surgeon for collection of UAW culture and had both UAW and
LAW cultures taken on the same day.
2.1. Microbiology
The UAW samples were taken by an ENT surgeon through
nasal endoscopy, specifically targeting for the sinus ostia. LAW
cultures were preferably taken from sputum. Sputum was
collected through expectoration with support from physiothe-
rapist when necessary. Only when there was no sputum
available a cough swab was taken.
All samples were streaked on blood agar, sabouraud dextrose
agar (SDA), mannitol salt agar, harmophilus chocolade agar,
McConkey ager and burkholderia cepacia (Bur-cep) plates in
duplicate and were incubated aerobically at 37 °C. Plates were
examined for growth and colonial morphology after 48 hours of
incubation. The cultureswere analysed for the existence of bacteria,
fungi and yeasts. For this study, we only evaluated the presence of
the following bacteria: P. aeruginosa (PA), S. aureus (SA),
H. influenzae, Escherichia coli, Klebsiella oxytoca, Klebsiella
pneumonia,Enterobacter cloacae, Stenotrophomonas maltophilia,
Streptococcus pneumonia and/or Burkholderia cepacia.
2.2. Lung function tests
Lung function was measured, using spirometry conform
international criteria [10]. For the measurements, a Lilly
pneumotachometer system (Viasys, Masterscreen, Hochberg,
Germany) was used and sex and height specific reference values
were applied [11,12]. The primary lung function parameter was
forced expiratory volume in one second as percentage of
predicted (FEV1% pred.) after inhalation with 800 µg salbuta-
mol. Spirometry was performed on the same day as the
collection of UAW and LAW cultures.
2.3. Symptoms and ENT examination:
Patients and their caretakers were asked for the presence of
one of the following symptoms: Cough, sputum production,nasal blockage, rhinorrhea and headache. Rhinological exam-
ination, using a nasal speculum, was performed by ENT
surgeons in all children from 4 years of age onwards, evaluating
the presence of nasal polyps, nasal discharge and mucosal
oedema.2.4. Statistics
Data were analysed with SPSS for Windows, version 15.0.
The primary outcome parameter was the number of cultures
positive for “any bacteria”, PA and SA. Descriptive statistics
were used to summarize the frequency of microorganisms in
these cultures. Differences between UAW and LAW culture
results were analysed using McNemar test. Differences in
clinical characteristics between patients with positive and
negative cultures were analysed using Chi-square test for
categorical variables and Mann Whitney U test or Indepen-
dent T-test for numerical variables. For multivariate analysis
logistic regression was conducted with isolation of micro-
organisms as a dependent variable and clinical variables, that
were found to be significant in univariate analyses, as
independent variables. A p-value of b0.05 was accepted as
statistically significant.3. Results
Of 238 patients, 81 were excluded from the study. In 56
patients UAW and LAW cultures were not available from the
same check up day, 18 patients were younger than 4 years and 7
patients older than 20 years. Table 1 shows the clinical
characteristics of the 157 included patients.
In our centre 40% of patients are chronically infected with
PA, conforming to the Lee criteria [13].
Table 2
Distribution of bacteria in lower and upper airway cultures (n=157).
Microorganisms LAW cultures UAW cultures p-value
Total positive cultures 125 (79.6%) 69 (43.9%) b0.001
P. aeruginosa 54 (34.4%) 18 (11.5%) b0.001
S. aureus 79 (50.3%) 42 (26.8%) b0.001
H. influenzae 17 (10.8%) 17 (10.8%) 1.00
E. coli 4 (2.5%) 2 (1.3%) 0.63
S. maltophilia 5 (3.2%) 0 (0%) 0.06
K. oxytoca 3 (1.9%) 2 (1.3%) 1.00
K. pneumoniae 2 (1.3%) 0 (0%) 0.50
E. cloacae 3 (1.9%) 1 (0.6%) 0.63
B. cepacia 1 (0.6%) 0 (0%) 1.00
S. pneumoniae 0 (0%) 3 (1.9%) 0.25
Data are given as number of positive cultures and percentage of total cultures.
N: number of patients. LAW: lower airways. UAW: upper airways.
Table 4
Clinical differences between patients with positive vs. negative culture results*.
Cultures Positive Negative p-value p-value
Univariate Multivariate
LAW all bacteria
Mean age, years 11.9 9.8 b0.05 0.05
Pulmonary history
Cough 86% 66% b0.05 0.98
Sputum production 74% 47% b0.05 b0.05
Ear–nose–throat exam
Nasal polyposis 57% 34% b0.05 b0.05
UAW all bacteria
Ear–nose–throat exam
Nasal discharge 51% 25% b0.001 b0.001
LAW P. aeruginosa
Mean age, years 12.9 10.8 b0.001 b0.05
Lung function
FEV1% pred. 85.4 92.5 b0.05 0.22
Pulmonary symptoms
Sputum production 81% 61% b0.05 0.08
UAW S. aureus
Ear–nose–throat exam
Nasal discharge 52% 30% b0.05 b0.05
Data are given as percentage of patients presenting with the specific clinical
symptom or mean age/lung function respectively. *Only significant results of
univariate analyses are shown.
Positive: group of patients with positive culture results. Negative: group of
patients with negative culture results. LAW: lower airways. UAW: upper
airways. N: number of patients.
FEV1% pred.: forced expiratory volume in 1 s expressed as % of predicted
values.
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Bacterial growth was found in 43.9% of the UAW cultures
and in 79.6% of the LAW cultures (pb0.001). Table 2 shows
the distribution of bacteria in the cultures. In over 50% of the
patients with a positive LAW culture the UAW culture was
negative. PA was found in 11.5% of the UAW vs. 34.4% of the
LAW cultures (pb0.001). In almost 80% of the patients with a
positive LAW culture for PA the UAW culture was negative
and in almost 7% of the patients with a negative LAW culture
the UAW culture was positive. SA was found in 26.8% of the
UAW culture and in 50.3% of the LAW cultures (pb0.001).
Positive and negative predictive values of UAW cultures were
86.9% and 26.1%, respectively for “all bacteria”, 61.1% and
69.1% for PA and 80.9% and 60.9% for SA in the LAW
cultures. These results are shown in Table 3.
In five of seven patients with a positive UAW and negative
LAW culture result for PA, the LAW culture became PA
positive within the next 3 months.
3.2. Clinical characteristics (Table 4)
Univariate analyses showed that patients with a positive
LAW culture (for all bacteria) were significantly older, hadTable 3
Cross tabs number of positive and negative lower versus upper airway cultures,
for “any bacteria”, P. aeruginosa and S. aureus.
LAW cultures UAW cultures
Positive Negative Total
Any bacteria Positive 60 65 125
Negative 9 23 32
Total 69 88 157
P. aeruginosa Positive 11 43 54
Negative 7 96 103
Total 18 139 157
S. aureus Positive 34 45 79
Negative 8 70 78
Total 42 115 157
Data are given as number of cultures. UAW: upper airways. LAW: lower
airways. Positive: microorganisms present in culture. Negative: microorganisms
not present in culture.more complaints of cough and sputum production and showed
more nasal polyposis compared to patients with a negative
LAW culture. After multivariate analyses these relations
remained significant, except for coughing (Table 4).
Patients with PA positive LAW culture were older, had a
worse lung function and more sputum production, after
multivariate analysis only the relation with age remained
significant. Patients with a positive UAW culture, both for all
bacteria and SA, had more nasal discharge, also after
multivariate analysis.
3.3. Follow up
From a subgroup of seven patients with a positive UAW and
negative LAW culture for PA, in one patient all LAW cultures
before and after the check up were positive for PA, suggesting
that the index culture was a false negative finding. But five
patients had no PA positive UAW or LAW culture before and 1
patient had a positive LAW culture once in the year before the
check up. In four of these six patients, the LAW cultures
became positive within 3 months.
4. Discussion
In daily practice, we found a significant difference between
simultaneously taken UAW and LAW cultures in children with
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patients with positive versus negative culture results, especially
when PA was cultured from the LAW. Besides, PA positive
UAW cultures appeared to precede positive LAW cultures in a
substantial part of patients.
We could confirm the difference between UAW and LAW
cultures in earlier, smaller studies, that compared cultures from
the oropharynx [14,15] middle meatus [16] or sinus wash outs
[17,18] with sputum or BAL fluid. Dosanjh et al. are the only
authors describing a high degree of correlation between results
of sinus cultures and trachea/sputum cultures [19]. Especially
the absence of PA from oropharyngeal cultures did not exclude
the presence of this microorganism in the lower respiratory
tract, as we confirmed in our study: in more than 30% of
patients with a negative UAW culture PA was found in the
LAW culture (Table 3). The positive and negative predictive
values of UAW cultures for PA in the LAW were low, 61.1 and
69.1%, respectively, comparable to earlier studies [14,18,20].
Not earlier described are the clinical characteristics of
patients with positive versus negative culture results. Especially
patients with PA positive LAW cultures were older and showed
more productive cough and worse lung function. These findings
could be expected and are in accordance with earlier findings in
patients with CF [21–23]. In patients with a positive UAW
culture (both for all bacteria and specifically for SA) we found
nasal discharge more often. This is probably caused by irritation
and inflammation of the nasal mucous membrane.
An important finding is that in four of six patients with a
positive UAW and negative LAW culture for PA, the LAW
became positive in the 3 months following the check up.
Although we did not genotype PA in this study our findings are
very suggestive for some kind of cross-infection between the
UAW and LAW, as suspected earlier by Mainz, Dosanjh and
Walter et al. [7,19,24]. Mainz et al. showed the presence of
identical genotypes for PA and SA in UAW and LAW cultures
[7]. We suspect that the UAW can function as a reservoir of
pathogens that spread to the LAW by cross-infection. This
cross-infection probably takes place due to direct contamination
through e.g. postnasal drip, swallowing, micro-aspiration or
tube feeding.
Our data and recent data from Mainz and Muhlebach et al.
strongly suggest that PA treatment targeting only the LAW
takes a risk of bypassing the UAW as a reservoir for spreading
microorganisms [7,18]. Addition of UAW treatment might
improve the success-rate of first PA eradication protocols and
PA positive UAW cultures might enable earlier treatment with
anti-Pseudomonas agents, thereby preventing LAW colonisa-
tion. Some centers already treat the UAW, but in most centers
these new devices are not available yet and there are no
consensus reports that mention these devices as the standard for
eradication treatment for PA. Further prospective clinical trials
are necessary to investigate if additional UAW treatment
improves the success rate of PA eradication.
The main limitation of the present study is the retrospective
design. However, the results of cultures in a prospective study
would probably have been the same and therefore this can
hardly be considered a real limitation. Also LAW samplesconcerned sputum in only 48.4% of patients. We did not
differentiate between sputum and cough swabs. The concor-
dance of sputum and cough swab cultures is still under debate,
but recent studies indicate that cultures from deep throat swab
and sputum give comparable results [25] and sputum and BAL
are equally able to detect PA colonisation [20]. The UAW
samples were taken through nasal endoscopy, specifically
targeting for the sinus ostia. A recent study from Mainz at al
suggested nasal lavage to be a preferable technique (over nasal
swab) for sampling the UAW [7]. However this technique needs
subject's cooperation and is therefore not suitable for younger
children. We were able to perform endoscopic sampling in all
children from the age of 4 years. A comparison of nasal lavage
with endoscopic sampling is an interesting subject for future
studies.
In conclusion, we found differences between results from
UAW and LAW cultures taken on the same day in children with
CF. UAW cultures do not reliably predict the presence of
pathogens in LAW cultures in these children. Patients with a
positive LAW culture were significantly older and had clear
LAW pathology, especially when PA was found. Patients with a
positive UAW culture (for all bacteria and especially SA) had
more UAW symptoms. We found that PA positive UAW
cultures preceded positive LAW cultures in a substantial part of
patients, suggesting some kind of cross-infection between the
UAW and LAW, a finding that should be taken in consideration
when treating CF patients with inhalation therapy.
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